Review of the Major Intervention Trials of Lowering Coronary Artery Disease Risk Through Cholesterol Reduction

This publication has 23 references indexed in Scilit:

• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
  The Lancet, 1994
• Baseline characteristics of subjects in the lipoprotein and coronary atherosclerosis study (LCAS) with fluvastatin
  The American Journal of Cardiology, 1994
• Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)
  The Lancet, 1992
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
  Journal of the American College of Cardiology, 1986
• SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN
  The Lancet, 1986
• Lipid research clinics coronary primary prevention trial: Results and implications
  The American Journal of Cardiology, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease
  JAMA, 1984
• A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
  Heart, 1978